SBOM for FDA Premarket Submissions for Cardiovascular Devices
FDA-aligned SBOMs for pacemakers, ICDs, monitors, and remote-follow cloud - implant firmware, programmer software, and 10+ year postmarket SBOM monitoring.
Aligned to FDA's February 3, 2026 premarket cybersecurity guidance.
Cardiovascular SBOM work is uniquely a postmarket problem. The implant ships, lives in a patient for 10+ years, and the SBOM you submitted on day one is the SBOM you have to maintain and monitor for the device's lifetime under FDA's postmarket cybersecurity guidance and Section 524B. Our SBOM service for this segment is built around that reality: a complete day-one SBOM across implant, programmer, home monitor, and cloud - plus a postmarket SBOM monitoring program that produces VEX-quality determinations as new CVEs land.
For the implant we extract third-party libraries from the firmware build (often a custom RTOS or proprietary scheduler) and document cryptographic libraries, communication stacks, and any open-source components - most implants have more OSS than their teams initially believe. The clinician programmer, typically Windows-based, gets a full OS + application SBOM. The home monitor gets an embedded-Linux-style SBOM. The remote-follow cloud (the highest churn surface) gets pipeline-integrated SBOM generation per build. We then operate ongoing monitoring against NVD/OSV/GHSA with auto-generated VEX drafts that your team triages - because for a 10-year deployed fleet, 'we'll review it next quarter' is not a postmarket cybersecurity strategy. Reports are formatted to slot directly into PMA Annual Reports and 524B postmarket plans.
Layers we exercise in this engagement
The cardiovascular system, from the outermost cloud and clinician surfaces down to the device itself. Highlighted layers are exercised by this medical device sbom services.
- 01Cloud backend libs Tested
- 02Mobile companion deps Tested
- 03Home-monitor firmware Tested
- 04Programmer software Tested
- 05Implant firmware components Tested
Layers shown outermost (top) to innermost (bottom). Dashed rows are part of the surrounding system but out of scope for this view.
Medical Device SBOM Services engagement, end to end
Four phases, fixed fee, scoped to cardiovascular architecture from kickoff onward.
- 01
Build-pipeline integration
SPDX 2.3 SBOMs generated from your actual build, not from runtime introspection alone.
- 02
Enrichment + triage
Components enriched from NVD, OSV, and GHSA; every CVE above your threshold triaged for exploitability.
- 03
VEX authoring
VEX statements (not_affected, affected, fixed, under_investigation) with documented justifications, where the manufacturer chooses to use VEX.
- 04
Postmarket handoff
SBOM + VEX delivery hooked into your QMS so postmarket monitoring continues after submission.
What we see in Cardiovascular medical device sbom services
The patterns we hit in this segment, this service, again and again.
Implant cryptographic library pulled in transitively
RNG / AES library inherited from a vendor SDK, never inventoried. Found via firmware-image SBOM extraction, not source-tree analysis.
Programmer Windows base components missing from SBOM
Application-only SBOM hides the OS attack surface. Programmer-side CVEs landed without product-team awareness for two cycles.
Cloud follow-up service SBOM not regenerated per build
Annual SBOM snapshot bears no resemblance to what's currently in production. Deployed components diverge silently from the regulatory record.
No postmarket VEX cadence
SBOM submitted and forgotten. New CVEs in OpenSSL / Linux kernel land with no exploitability determination on file when reviewers ask.
"Blue Goat Cyber helped us navigate our first end-to-end cybersecurity testing for our wearable medical device. Their communication was excellent, their timeline exceeded expectations, and their report helped us achieve FDA clearance without any additional questions. It was a truly seamless experience."
Standard Medical Device SBOM Services deliverables
The same deliverables the parent Medical Device SBOM Services service ships with - tuned to your cardiovascular architecture.
- SPDX and CycloneDX generation
- Component vulnerability mapping (CVE / KEV)
- End-of-life and replacement planning
- Build-system and binary SCA validation
What lands in your eSTAR submission
Documents structured for the cybersecurity attachments of your submission - no reformatting on your side.
- SPDX and CycloneDX generation
- Component vulnerability mapping (CVE / KEV)
- End-of-life and replacement planning
- Build-system and binary SCA validation
Standards that apply
The Cardiovascular baseline, plus the call-outs that matter for medical device sbom services in this segment.
Segment-specific call-outs
FDA postmarket cybersecurity guidance + 524B postmarket clauses
Cardiac fleets are the canonical use case - SBOM monitoring is not optional for this segment.
AAMI TIR97
Postmarket cyber surveillance framework FDA reviewers explicitly reference for implant fleets.
What's not in scope
We scope tightly on purpose. These items are either out-of-scope by design or belong in a separate engagement - we'll tell you up front, not after kickoff.
- Penetration testing of components in the SBOM
- Code refactoring to remove vulnerable dependencies
- License-compliance legal review (we surface, your counsel rules)
Medical Device SBOM Services for Cardiovascular - FAQs
The questions buyers in this segment actually ask before scoping a medical device sbom services engagement.
Go deeper on Cardiovascular and premarket
A practical, ungated buyer's guide for medical device manufacturers evaluating cybersecurity partners, what goes wrong, why it costs you, and what to demand from your next engagement. Aligned to the FDA February 2026 premarket guidance.
The most common high- and critical-severity findings we surface in medical device penetration tests, what each one looks like in the field, and how to fix it before your FDA submission.
A practical, ungated guide to the threat modeling gaps that trigger FDA cybersecurity questions in 510(k), De Novo, and PMA submissions - and exactly how to close them before reviewers find them.
Medical device cybersecurity should scale with device risk. Christian Espinosa argues why meeting only the Section 524B minimum leaves patients and submissions exposed.
VEX resources for medical device teams: a document guide, SBOM comparison, and common assessment mistakes, with evidence-based status and regulatory context.
Medical device cybersecurity for nanotech neurostimulation: a fictional STRIDE threat model linking controller risks, patient harms, controls, and testing.
Other engagements for Cardiovascular
Teams in this segment commonly bundle these alongside medical device sbom services.
Keep going
Scope a Medical Device SBOM Services engagement for your cardiovascular program.
A 30-minute discovery call with Christian Espinosa, Founder and CEO, and Kristy Kennedy, VP of Sales.